BCI is a semi-allosteric inhibitor of both DUSP1 and DUSP6 and several studies have demonstrated that BCI phenocopies genetic DUSP6 inhibition in cancer (Kong et al, 2023; Ramkissoon et al, 2019; Shojaee et al, 2015). The gene discussed is DUSP6; the disease is cancer.